Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02991898 · FLOW

Participant flow

Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies · Source last updated 2020-09-29

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    The Treg cell infusion is given no sooner than 1 hour, but within 24 hours after the 2nd cord blood infusion
    id
    FG000
    title
    Treg Infusion
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        3
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        3
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    The Treg cell infusion is given no sooner than 1 hour, but within 24 hours after the 2nd cord blood infusion
    id
    FG000
    title
    Treg Infusion
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        3
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        3
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice